Forbidden Foods Limited (ASX:FFF) CEO and Managing Director Alex Aleksic provides an introduction to the company, discussing its recent acquisition of Good Oats.
Topics covered include:
Copyright 2024 – Finance News Network
Source: Finance News Network
10 Oct 2023 - Dean Tuck - Managing Director - Dreadnought Resources (ASX:DRE) is a highly active West Australian mineral explorer focused on finding the metals needed now and in the future.
Read More03 Jun 2021 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses the company's growth strategy, outlook and its product suite for supporting employee communication and collaboration.
Read More30 Jul 2024 - Cristian Moreno - Managing Director - Torque Metals (ASX:TOR) is an exploration company with a proven discovery methodology, combining drilling results with machine learning algorithms and geological interpretation.
Read More21 May 2021 - Hazer Group Limited (ASX:HZR) CEO & Managing Director Geoff Ward provides an update on the company's Commercial Development Project at the Woodman Point Wastewater Treatment Plant south of Perth, a 100 tonne per annum hydrogen production facility using waste gas produced through the water treatment facilities.
Read More04 Sep 2019 - Lithium Power International Limited (ASX:LPI) Executive Director - Corporate Finance, Richard Crookes, provides an update on the company's portfolio, starting with its key Maricunga lithium brine project in Northern Chile and hard rock lithium in WA.
Read More13 Sep 2024 - Control Bionics Limited (ASX:CBL) CEO Jeremy Steele provides an overview of the company, discussing its suite of augmentative and alternative communication products.
Read More17 Aug 2022 - CARETEQ Limited (ASX:CTQ) Executive Chairman Mark Simari discusses the company's recent agreement with drug management platform StrongRoom AI and the transition from paper-based to digital record keeping within the aged care and assistive living sector.
Read More07 Feb 2025 - Capital Prudential's Sam Moore on unlocking property development opportunities.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
